Sinco Pharmaceutical Holdings (HKSE:06833) Change In Receivables : HK$-214 Mil (TTM As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is Sinco Pharmaceutical Holdings Change In Receivables?

Sinco Pharmaceutical Holdings's change in receivables for the quarter that ended in Dec. 2023 was HK$-263 Mil. It means Sinco Pharmaceutical Holdings's Accounts Receivable increased by HK$263 Mil from Jun. 2023 to Dec. 2023 .

Sinco Pharmaceutical Holdings's change in receivables for the fiscal year that ended in Dec. 2023 was HK$-214 Mil. It means Sinco Pharmaceutical Holdings's Accounts Receivable increased by HK$214 Mil from Dec. 2022 to Dec. 2023 .

Sinco Pharmaceutical Holdings's Accounts Receivable for the quarter that ended in Dec. 2023 was HK$586 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Sinco Pharmaceutical Holdings's Days Sales Outstanding for the six months ended in Dec. 2023 was 67.47.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Sinco Pharmaceutical Holdings's liquidation value for the six months ended in Dec. 2023 was HK$-403 Mil.

Sinco Pharmaceutical Holdings Change In Receivables Historical Data

The historical data trend for Sinco Pharmaceutical Holdings's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinco Pharmaceutical Holdings Change In Receivables Chart

Sinco Pharmaceutical Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

-6.52

-649.18

445.77

-149.50

-214.26

Sinco Pharmaceutical Holdings Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Change In Receivables	Get a 7-Day Free Trial														101.71	-29.46	-121.43	48.69	-262.95

Sinco Pharmaceutical Holdings Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-214 Mil.

Sinco Pharmaceutical Holdings (HKSE:06833) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Sinco Pharmaceutical Holdings's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	586.304	/	1585.91	*	91
=	67.47

2. In Ben Graham's calculation of liquidation value, Sinco Pharmaceutical Holdings's accounts receivable are only considered to be worth 75% of book value:

Sinco Pharmaceutical Holdings's liquidation value for the quarter that ended in Dec. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	478.99	-	1381.034	+	0.75 * 586.304	+	0.5 * 118.157
=	-403

Sinco Pharmaceutical Holdings Change In Receivables Related Terms

Thank you for viewing the detailed overview of Sinco Pharmaceutical Holdings's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Sinco Pharmaceutical Holdings (HKSE:06833) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Sinco Pharmaceutical Holdings Ltd (HKSE:06833) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 1700, North Section of Tianfu Avenue, E5-1805, Global Centre, High-Tech Zone, Chengdu, Sichuan Province, Chengdu, CHN

Website

https://www.sinco-pharm.com

Sinco Pharmaceutical Holdings Ltd is an investment holding company engaged in the provision of comprehensive marketing, promotion, and channel management service for imported pharmaceutical products and medical devices in China. The company has three operating segments; the sale of imported pharmaceutical products segment, the research and manufacturing of aesthetic medicine segment, and the medical beauty services segment. Its product offering includes Human albumin solutions and Antibiotics like Axetine and Medocef.

Executives

Huang Zhijian	2305 Beneficiary of a trust
Fullwealth Holdings Limited	2201 Interest of corporation controlled by you
Risun Investments Limited	2101 Beneficial owner
Wickhams Cay Trust Company Limited	2301 Trustee
Huang Xiangbin	2307 Founder of a discretionary trust who can infl

Sinco Pharmaceutical Holdings (HKSE:06833) Headlines

No Headlines